speb/financial-data huggingface dataset:
LUNG cash_flow (annual, 2023-12-31) — Changes In Cash: -18217000.00
LUNG balance_sheet (annual, 2023-12-31) — Common Stock: 39000.00
LUNG balance_sheet (annual, 2023-12-31) — Common Stock Equity: 118315000.00
LUNG balance_sheet (annual, 2023-12-31) — Construction In Progress: 2199000.00
LUNG income_statement (annual, 2023-12-31) — Cost Of Revenue: 17923000.00
LUNG balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 7596000.00
LUNG balance_sheet (annual, 2023-12-31) — Current Assets: 150422000.00
LUNG balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3074000.00
LUNG balance_sheet (annual, 2023-12-31) — Current Debt: 2155000.00
LUNG balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5229000.00
LUNG balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 104000.00
LUNG balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 104000.00
LUNG balance_sheet (annual, 2023-12-31) — Current Liabilities: 23157000.00
LUNG cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1548000.00
LUNG cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1548000.00
LUNG income_statement (annual, 2023-12-31) — Diluted Average Shares: 37974567.00
LUNG income_statement (annual, 2023-12-31) — Diluted EPS: -1.60
LUNG income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -60843000.00
LUNG income_statement (annual, 2023-12-31) — EBIT: -57040000.00
LUNG income_statement (annual, 2023-12-31) — EBITDA: -55492000.00
LUNG cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 34000.00
LUNG cash_flow (annual, 2023-12-31) — End Cash Position: 83784000.00
LUNG cash_flow (annual, 2023-12-31) — Financing Cash Flow: 21400000.00
LUNG cash_flow (annual, 2023-12-31) — Free Cash Flow: -38417000.00
LUNG cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -15000.00
LUNG balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 2640000.00
LUNG balance_sheet (annual, 2023-12-31) — Goodwill: 2333000.00
LUNG balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2364000.00
LUNG balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 12105000.00
LUNG balance_sheet (annual, 2023-12-31) — Gross PPE: 12289000.00
LUNG income_statement (annual, 2023-12-31) — Gross Profit: 50752000.00
LUNG cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 471000.00
LUNG balance_sheet (annual, 2023-12-31) — Income Tax Payable: 93000.00
LUNG income_statement (annual, 2023-12-31) — Interest Expense: 3232000.00
LUNG income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3232000.00
LUNG income_statement (annual, 2023-12-31) — Interest Income: 5568000.00
LUNG income_statement (annual, 2023-12-31) — Interest Income Non Operating: 5568000.00
LUNG cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 2984000.00
LUNG balance_sheet (annual, 2023-12-31) — Inventory: 16743000.00
LUNG balance_sheet (annual, 2023-12-31) — Invested Capital: 155559000.00
LUNG cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2007000.00
LUNG balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 14390000.00
LUNG balance_sheet (annual, 2023-12-31) — Investments And Advances: 14390000.00
LUNG cash_flow (annual, 2023-12-31) — Issuance Of Debt: 20000000.00
LUNG balance_sheet (annual, 2023-12-31) — Leases: 2277000.00
LUNG balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1106000.00
LUNG balance_sheet (annual, 2023-12-31) — Long Term Debt: 35089000.00
LUNG balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 36195000.00
LUNG cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 20000000.00
LUNG cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -94000.00
LUNG balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 4407000.00
LUNG income_statement (annual, 2023-12-31) — Net Income: -60843000.00
LUNG income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -60843000.00
LUNG income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -60843000.00
LUNG income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -60843000.00
LUNG income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -60843000.00
LUNG cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -60843000.00
LUNG income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -60843000.00
LUNG income_statement (annual, 2023-12-31) — Net Interest Income: 2336000.00
LUNG cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1200000.00
LUNG cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 19906000.00
LUNG cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 19906000.00
LUNG income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 2336000.00
LUNG balance_sheet (annual, 2023-12-31) — Net PPE: 7434000.00
LUNG cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -807000.00
LUNG balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 115951000.00
LUNG balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 114000.00
LUNG balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 114000.00
LUNG income_statement (annual, 2023-12-31) — Normalized EBITDA: -55492000.00
LUNG income_statement (annual, 2023-12-31) — Normalized Income: -60843000.00
LUNG cash_flow (annual, 2023-12-31) — Operating Cash Flow: -37610000.00
LUNG cash_flow (annual, 2023-12-31) — Operating Gains Losses: -15000.00
LUNG income_statement (annual, 2023-12-31) — Operating Income: -61935000.00
LUNG income_statement (annual, 2023-12-31) — Operating Revenue: 68675000.00
LUNG balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 38516383.00
LUNG balance_sheet (annual, 2023-12-31) — Other Current Assets: 504000.00
LUNG balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2155000.00
LUNG balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 2640000.00
LUNG income_statement (annual, 2023-12-31) — Other Income Expense: -673000.00
LUNG balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 31000.00
LUNG cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2734000.00
LUNG balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 3171000.00
LUNG income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -673000.00
LUNG balance_sheet (annual, 2023-12-31) — Other Properties: 3406000.00
LUNG balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 33555000.00
LUNG balance_sheet (annual, 2023-12-31) — Payables: 2353000.00
LUNG balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 9949000.00
LUNG balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7875000.00
LUNG balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
LUNG balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2816000.00
LUNG income_statement (annual, 2023-12-31) — Pretax Income: -60272000.00
LUNG cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1494000.00
LUNG balance_sheet (annual, 2023-12-31) — Properties: 0.00
LUNG cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -59000.00
LUNG cash_flow (annual, 2023-12-31) — Purchase Of Investment: -46200000.00
LUNG cash_flow (annual, 2023-12-31) — Purchase Of PPE: -807000.00
LUNG balance_sheet (annual, 2023-12-31) — Receivables: 13020000.00
LUNG income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 17923000.00
LUNG income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1548000.00
LUNG cash_flow (annual, 2023-12-31) — Repayment Of Debt: -94000.00
LUNG income_statement (annual, 2023-12-31) — Research And Development: 18080000.00
LUNG balance_sheet (annual, 2023-12-31) — Restricted Cash: 237000.00
LUNG balance_sheet (annual, 2023-12-31) — Retained Earnings: -411161000.00
LUNG cash_flow (annual, 2023-12-31) — Sale Of Investment: 45000000.00
LUNG income_statement (annual, 2023-12-31) — Selling General And Administration: 94607000.00
LUNG balance_sheet (annual, 2023-12-31) — Share Issued: 38516383.00
LUNG cash_flow (annual, 2023-12-31) — Stock Based Compensation: 22101000.00
LUNG balance_sheet (annual, 2023-12-31) — Stockholders Equity: 118315000.00
LUNG balance_sheet (annual, 2023-12-31) — Tangible Book Value: 115951000.00
LUNG income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (annual, 2023-12-31) — Tax Provision: 571000.00
LUNG income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
LUNG balance_sheet (annual, 2023-12-31) — Taxes Receivable: 915000.00
LUNG balance_sheet (annual, 2023-12-31) — Total Assets: 177781000.00
LUNG balance_sheet (annual, 2023-12-31) — Total Capitalization: 153404000.00
LUNG balance_sheet (annual, 2023-12-31) — Total Debt: 41424000.00
LUNG balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 118315000.00
LUNG income_statement (annual, 2023-12-31) — Total Expenses: 130610000.00
LUNG balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 59466000.00
LUNG balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 27359000.00
LUNG balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 36309000.00
LUNG income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -61935000.00
LUNG balance_sheet (annual, 2023-12-31) — Total Tax Payable: 856000.00
LUNG balance_sheet (annual, 2023-12-31) — Working Capital: 127265000.00
LUNG cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
LUNG balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 0.00
LUNG balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 0.00
LUNG cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
LUNG cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
LUNG cash_flow (quarterly, 2024-09-30) — Provisionand Write Offof Assets: 0.00
LUNG income_statement (annual, 2024-12-31) — +Operating Expense: 119705000.00
LUNG income_statement (annual, 2024-12-31) — +Total Revenue: 83789000.00
LUNG balance_sheet (annual, 2024-12-31) — Accounts Payable: 3827000.00
LUNG balance_sheet (annual, 2024-12-31) — Accounts Receivable: 13120000.00
LUNG balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5724000.00
LUNG balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 551211000.00
LUNG balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -100000.00
LUNG cash_flow (annual, 2024-12-31) — Amortization Of Securities: -1616000.00
LUNG cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1792000.00
LUNG income_statement (annual, 2024-12-31) — Basic Average Shares: 39111073.00
LUNG income_statement (annual, 2024-12-31) — Basic EPS: -1.44
LUNG cash_flow (annual, 2024-12-31) — Beginning Cash Position: 83784000.00
LUNG cash_flow (annual, 2024-12-31) — Capital Expenditure: -1447000.00
LUNG balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 19293000.00
LUNG balance_sheet (annual, 2024-12-31) — Capital Stock: 40000.00
LUNG balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 70905000.00
LUNG balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 101482000.00
LUNG balance_sheet (annual, 2024-12-31) — Cash Equivalents: 6616000.00
LUNG balance_sheet (annual, 2024-12-31) — Cash Financial: 64289000.00
LUNG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1363000.00
LUNG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 17476000.00
LUNG cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -31537000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Account Payable: 2278000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 462000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -38000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Inventory: -229000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -546000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -1870000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -16000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Payable: 2240000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2702000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -436000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Receivables: -1308000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Tax Payable: -38000.00
LUNG cash_flow (annual, 2024-12-31) — Change In Working Capital: -1703000.00
LUNG cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1308000.00
LUNG cash_flow (annual, 2024-12-31) — Changes In Cash: -12698000.00
LUNG balance_sheet (annual, 2024-12-31) — Common Stock: 40000.00
LUNG balance_sheet (annual, 2024-12-31) — Common Stock Equity: 85809000.00
LUNG balance_sheet (annual, 2024-12-31) — Construction In Progress: 206000.00
LUNG income_statement (annual, 2024-12-31) — Cost Of Revenue: 21788000.00
LUNG balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 8751000.00
LUNG balance_sheet (annual, 2024-12-31) — Current Assets: 136248000.00
LUNG balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 778000.00
LUNG balance_sheet (annual, 2024-12-31) — Current Debt: 3176000.00
LUNG balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 3954000.00
LUNG balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 135000.00
LUNG balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 135000.00
LUNG balance_sheet (annual, 2024-12-31) — Current Liabilities: 24437000.00
LUNG cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1493000.00
LUNG cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1493000.00
LUNG income_statement (annual, 2024-12-31) — Diluted Average Shares: 39111073.00
LUNG income_statement (annual, 2024-12-31) — Diluted EPS: -1.44
LUNG income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -56394000.00
LUNG income_statement (annual, 2024-12-31) — EBIT: -52387000.00
LUNG income_statement (annual, 2024-12-31) — EBITDA: -50894000.00
LUNG cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 76000.00
LUNG cash_flow (annual, 2024-12-31) — End Cash Position: 71162000.00
LUNG cash_flow (annual, 2024-12-31) — Financing Cash Flow: 1363000.00
LUNG cash_flow (annual, 2024-12-31) — Free Cash Flow: -32984000.00
LUNG cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
LUNG cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
LUNG balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2113000.00
LUNG balance_sheet (annual, 2024-12-31) — Goodwill: 2333000.00
LUNG balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 2333000.00
LUNG balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 13220000.00
LUNG balance_sheet (annual, 2024-12-31) — Gross PPE: 27176000.00
LUNG income_statement (annual, 2024-12-31) — Gross Profit: 62001000.00
LUNG cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 556000.00
LUNG balance_sheet (annual, 2024-12-31) — Income Tax Payable: 49000.00
LUNG income_statement (annual, 2024-12-31) — Interest Expense: 3507000.00
LUNG income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3507000.00
LUNG income_statement (annual, 2024-12-31) — Interest Income: 5061000.00
LUNG income_statement (annual, 2024-12-31) — Interest Income Non Operating: 5061000.00
LUNG cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 3482000.00
LUNG balance_sheet (annual, 2024-12-31) — Inventory: 16915000.00
LUNG balance_sheet (annual, 2024-12-31) — Invested Capital: 122987000.00
LUNG cash_flow (annual, 2024-12-31) — Investing Cash Flow: 17476000.00
LUNG balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
LUNG balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 0.00
LUNG balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
LUNG balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
LUNG cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
LUNG cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
LUNG balance_sheet (annual, 2024-12-31) — Leases: 2318000.00
LUNG balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 18515000.00
LUNG balance_sheet (annual, 2024-12-31) — Long Term Debt: 34002000.00
LUNG balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 52517000.00
LUNG cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
LUNG cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
LUNG cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -95000.00
LUNG balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 6107000.00
LUNG income_statement (annual, 2024-12-31) — Net Income: -56394000.00
LUNG income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -56394000.00
LUNG income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -56394000.00
LUNG income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -56394000.00
LUNG income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -56394000.00
LUNG cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -56394000.00
LUNG income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -56394000.00
LUNG income_statement (annual, 2024-12-31) — Net Interest Income: 1554000.00
LUNG cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 18923000.00
LUNG cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -95000.00
LUNG cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -95000.00
LUNG income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1554000.00
LUNG balance_sheet (annual, 2024-12-31) — Net PPE: 21452000.00
LUNG cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1447000.00
LUNG balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 83476000.00
LUNG balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 87000.00
LUNG balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 87000.00
LUNG income_statement (annual, 2024-12-31) — Normalized EBITDA: -50894000.00
LUNG income_statement (annual, 2024-12-31) — Normalized Income: -56394000.00
LUNG cash_flow (annual, 2024-12-31) — Operating Cash Flow: -31537000.00
LUNG income_statement (annual, 2024-12-31) — Operating Income: -57704000.00
LUNG income_statement (annual, 2024-12-31) — Operating Revenue: 83789000.00
LUNG balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 39785969.00
LUNG balance_sheet (annual, 2024-12-31) — Other Current Assets: 1129000.00
LUNG balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 3176000.00
LUNG balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 2113000.00
LUNG income_statement (annual, 2024-12-31) — Other Income Expense: 256000.00
LUNG cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1896000.00
LUNG balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2817000.00
LUNG income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 256000.00
LUNG balance_sheet (annual, 2024-12-31) — Other Properties: 18545000.00
LUNG balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 30577000.00
LUNG balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 30577000.00
LUNG balance_sheet (annual, 2024-12-31) — Payables: 4703000.00
LUNG balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 13454000.00
LUNG balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6894000.00
LUNG balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
LUNG balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2674000.00
LUNG income_statement (annual, 2024-12-31) — Pretax Income: -55894000.00
LUNG cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1458000.00
LUNG balance_sheet (annual, 2024-12-31) — Properties: 0.00
LUNG cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 40000.00
LUNG cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 0.00
LUNG cash_flow (annual, 2024-12-31) — Purchase Of Investment: -27914000.00
LUNG cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1447000.00
LUNG balance_sheet (annual, 2024-12-31) — Receivables: 13791000.00
LUNG income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 21788000.00
LUNG income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1493000.00
LUNG cash_flow (annual, 2024-12-31) — Repayment Of Debt: -95000.00
LUNG income_statement (annual, 2024-12-31) — Research And Development: 17570000.00
LUNG balance_sheet (annual, 2024-12-31) — Restricted Cash: 257000.00
LUNG balance_sheet (annual, 2024-12-31) — Retained Earnings: -467555000.00
LUNG cash_flow (annual, 2024-12-31) — Sale Of Investment: 46837000.00
LUNG income_statement (annual, 2024-12-31) — Selling General And Administration: 102135000.00
LUNG balance_sheet (annual, 2024-12-31) — Share Issued: 39785969.00
LUNG cash_flow (annual, 2024-12-31) — Stock Based Compensation: 22955000.00
LUNG balance_sheet (annual, 2024-12-31) — Stockholders Equity: 85809000.00
LUNG balance_sheet (annual, 2024-12-31) — Tangible Book Value: 83476000.00
LUNG income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (annual, 2024-12-31) — Tax Provision: 500000.00
LUNG income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
LUNG balance_sheet (annual, 2024-12-31) — Taxes Receivable: 671000.00
LUNG balance_sheet (annual, 2024-12-31) — Total Assets: 162850000.00
LUNG balance_sheet (annual, 2024-12-31) — Total Capitalization: 119811000.00
LUNG balance_sheet (annual, 2024-12-31) — Total Debt: 56471000.00
LUNG balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 85809000.00
LUNG income_statement (annual, 2024-12-31) — Total Expenses: 141493000.00
LUNG balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 77041000.00
LUNG balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 26602000.00
LUNG balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 52604000.00
LUNG income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -57704000.00
LUNG balance_sheet (annual, 2024-12-31) — Total Tax Payable: 876000.00
LUNG balance_sheet (annual, 2024-12-31) — Working Capital: 111811000.00
LUNG income_statement (quarterly, 2025-03-31) — +Operating Expense: 30905000.00
LUNG income_statement (quarterly, 2025-03-31) — +Total Revenue: 22538000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4280000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 13975000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6007000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 557428000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -100000.00
LUNG cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -206000.00
LUNG cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: -46000.00
LUNG income_statement (quarterly, 2025-03-31) — Basic Average Shares: 39954658.00
LUNG income_statement (quarterly, 2025-03-31) — Basic EPS: -0.36
LUNG cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 71162000.00
LUNG cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -301000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 19753000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Capital Stock: 40000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 74555000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 88702000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 12011000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Cash Financial: 62544000.00
LUNG cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 664000.00
LUNG cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 16313000.00
LUNG cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -13222000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 505000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -4891000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 24000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Inventory: 406000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -369000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -37000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -8000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Payable: 529000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4362000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 308000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Receivables: -721000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 24000.00
LUNG cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -4783000.00
LUNG cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -721000.00
LUNG cash_flow (quarterly, 2025-03-31) — Changes In Cash: 3755000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Common Stock: 40000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 77667000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 80000.00
LUNG income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6196000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 7946000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Current Assets: 123939000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1101000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Current Debt: 7803000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 8904000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 128000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 128000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 24945000.00
LUNG cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 278000.00
LUNG cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 278000.00
LUNG income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 39954658.00
LUNG income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.36
LUNG income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -14448000.00
LUNG income_statement (quarterly, 2025-03-31) — EBIT: -13532000.00
LUNG income_statement (quarterly, 2025-03-31) — EBITDA: -13254000.00
LUNG cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -105000.00
LUNG cash_flow (quarterly, 2025-03-31) — End Cash Position: 74812000.00
LUNG cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 664000.00
LUNG cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -13523000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2202000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Goodwill: 2333000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2333000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 14075000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Gross PPE: 27515000.00
LUNG income_statement (quarterly, 2025-03-31) — Gross Profit: 16342000.00
LUNG cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 109000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 86000.00
LUNG income_statement (quarterly, 2025-03-31) — Interest Expense: 781000.00
LUNG income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 781000.00
LUNG income_statement (quarterly, 2025-03-31) — Interest Income: 864000.00
LUNG income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 864000.00
LUNG cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 788000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Inventory: 16809000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Invested Capital: 114863000.00
LUNG cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 16313000.00
LUNG cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
LUNG balance_sheet (quarterly, 2025-03-31) — Leases: 2335000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 18652000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 29393000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 48045000.00
LUNG cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
LUNG cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
LUNG balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 6418000.00
LUNG income_statement (quarterly, 2025-03-31) — Net Income: -14448000.00
LUNG income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -14448000.00
LUNG income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -14448000.00
LUNG income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -14448000.00
LUNG income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -14448000.00
LUNG cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -14448000.00
LUNG income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -14448000.00
LUNG income_statement (quarterly, 2025-03-31) — Net Interest Income: 83000.00
LUNG cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 16614000.00
LUNG cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
LUNG cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
LUNG income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 83000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Net PPE: 21508000.00
LUNG cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -301000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 75334000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 79000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 79000.00
LUNG income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -13254000.00
LUNG income_statement (quarterly, 2025-03-31) — Normalized Income: -14448000.00
LUNG cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -13222000.00
LUNG income_statement (quarterly, 2025-03-31) — Operating Income: -14563000.00
LUNG income_statement (quarterly, 2025-03-31) — Operating Revenue: 22538000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 40247480.00
LUNG balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 274000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 7803000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 2202000.00
LUNG income_statement (quarterly, 2025-03-31) — Other Income Expense: 167000.00
LUNG cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 371000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2956000.00
LUNG income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 167000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Other Properties: 18682000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 14147000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Payables: 5000000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 12946000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2967000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
LUNG balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 3295000.00
LUNG income_statement (quarterly, 2025-03-31) — Pretax Income: -14313000.00
LUNG cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 664000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
LUNG cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -3921000.00
LUNG cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -301000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Receivables: 14602000.00
LUNG income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 6196000.00
LUNG income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 278000.00
LUNG cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
LUNG income_statement (quarterly, 2025-03-31) — Research And Development: 4756000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 257000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -482003000.00
LUNG cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 20535000.00
LUNG income_statement (quarterly, 2025-03-31) — Selling General And Administration: 26149000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Share Issued: 40247480.00
LUNG cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 5612000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 77667000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 75334000.00
LUNG income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (quarterly, 2025-03-31) — Tax Provision: 135000.00
LUNG income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
LUNG balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 627000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Total Assets: 150736000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 107060000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Total Debt: 56949000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 77667000.00
LUNG income_statement (quarterly, 2025-03-31) — Total Expenses: 37101000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 73069000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 26797000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 48124000.00
LUNG income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -14563000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 720000.00
LUNG balance_sheet (quarterly, 2025-03-31) — Working Capital: 98994000.00
LUNG income_statement (quarterly, 2025-06-30) — +Operating Expense: 32008000.00
LUNG income_statement (quarterly, 2025-06-30) — +Total Revenue: 23859000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 6557000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 15903000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -6299000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 563589000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -100000.00
LUNG cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -133000.00
LUNG cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: -50000.00
LUNG income_statement (quarterly, 2025-06-30) — Basic Average Shares: 40429655.00
LUNG income_statement (quarterly, 2025-06-30) — Basic EPS: -0.38
LUNG cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 74812000.00
LUNG cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -49000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 19713000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Capital Stock: 41000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 75466000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 84225000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 3151000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Cash Financial: 72315000.00
LUNG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -67000.00
LUNG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 5471000.00
LUNG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3908000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 2140000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 2527000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: 68000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Inventory: 660000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 10000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -256000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -53000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Payable: 2208000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 4735000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 791000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1220000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: 68000.00
LUNG cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 4667000.00
LUNG cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -1220000.00
LUNG cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1496000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Common Stock: 41000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 69090000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 20000.00
LUNG income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 6655000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 9495000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Current Assets: 120020000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1115000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Current Debt: 104000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1219000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 78000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 78000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 22447000.00
LUNG cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 299000.00
LUNG cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 299000.00
LUNG income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 40429655.00
LUNG income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.38
LUNG income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -15173000.00
LUNG income_statement (quarterly, 2025-06-30) — EBIT: -14197000.00
LUNG income_statement (quarterly, 2025-06-30) — EBITDA: -13898000.00
LUNG cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -583000.00
LUNG cash_flow (quarterly, 2025-06-30) — End Cash Position: 75725000.00
LUNG cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -67000.00
LUNG cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3957000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2636000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Goodwill: 2333000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2333000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 16003000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Gross PPE: 27602000.00
LUNG income_statement (quarterly, 2025-06-30) — Gross Profit: 17204000.00
LUNG cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 105000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 205000.00
LUNG income_statement (quarterly, 2025-06-30) — Interest Expense: 799000.00
LUNG income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 799000.00
LUNG income_statement (quarterly, 2025-06-30) — Interest Income: 723000.00
LUNG income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 723000.00
LUNG cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 784000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Inventory: 16175000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Invested Capital: 106205000.00
LUNG cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 5471000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Leases: 2336000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 18598000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 37011000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 55609000.00
LUNG cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -48000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 6603000.00
LUNG income_statement (quarterly, 2025-06-30) — Net Income: -15173000.00
LUNG income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -15173000.00
LUNG income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -15173000.00
LUNG income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -15173000.00
LUNG income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -15173000.00
LUNG cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -15173000.00
LUNG income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -15173000.00
LUNG income_statement (quarterly, 2025-06-30) — Net Interest Income: -76000.00
LUNG cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 5520000.00
LUNG cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -48000.00
LUNG cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -48000.00
LUNG income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -76000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Net PPE: 21303000.00
LUNG cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -49000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 66757000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 41000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 41000.00
LUNG income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -13898000.00
LUNG income_statement (quarterly, 2025-06-30) — Normalized Income: -15173000.00
LUNG cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -3908000.00
LUNG income_statement (quarterly, 2025-06-30) — Operating Income: -14804000.00
LUNG income_statement (quarterly, 2025-06-30) — Operating Revenue: 23859000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 40743806.00
LUNG balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 124000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 104000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2636000.00
LUNG income_statement (quarterly, 2025-06-30) — Other Income Expense: -116000.00
LUNG cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 268000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 3531000.00
LUNG income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -116000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Other Properties: 18643000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 8759000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Payables: 7654000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 17149000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 4001000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
LUNG balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2838000.00
LUNG income_statement (quarterly, 2025-06-30) — Pretax Income: -14996000.00
LUNG cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 28000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
LUNG cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1730000.00
LUNG cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -49000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Receivables: 16399000.00
LUNG income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 6655000.00
LUNG income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 299000.00
LUNG cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -48000.00
LUNG income_statement (quarterly, 2025-06-30) — Research And Development: 5306000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 259000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -497176000.00
LUNG cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 7250000.00
LUNG income_statement (quarterly, 2025-06-30) — Selling General And Administration: 26702000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Share Issued: 40743806.00
LUNG cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6214000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 69090000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 66757000.00
LUNG income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (quarterly, 2025-06-30) — Tax Provision: 177000.00
LUNG income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
LUNG balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 496000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Total Assets: 147187000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 106101000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Total Debt: 56828000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 69090000.00
LUNG income_statement (quarterly, 2025-06-30) — Total Expenses: 38663000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 78097000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 27167000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 55650000.00
LUNG income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -14804000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1097000.00
LUNG balance_sheet (quarterly, 2025-06-30) — Working Capital: 97573000.00
LUNG income_statement (quarterly, 2025-09-30) — +Operating Expense: 30445000.00
LUNG income_statement (quarterly, 2025-09-30) — +Total Revenue: 21502000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 6420000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 13797000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -6558000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 568887000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -100000.00
LUNG cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -40000.00
LUNG cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 72000.00
LUNG income_statement (quarterly, 2025-09-30) — Basic Average Shares: 40936896.00
LUNG income_statement (quarterly, 2025-09-30) — Basic EPS: -0.34
LUNG cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 75725000.00
LUNG cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -89000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 19434000.00